Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-04-18

Clinical Trial Update: Effects of Home-Based Emotional Disclosure in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating whether home-based emotional disclosure impacts symptoms and quality of life in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: UMC Utrecht | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED